ALMS

Equibles Rating blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 16.9 · calm Equity put/call 0.86

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +64%

above

Price vs 50-day avg +25%

above

RSI (14) 71

overbought

MACD trend Positive

52-week position 95%

near high

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Strong

1-month return +54%

trailing

6-month return +39%

trailing

YTD return +200%

this year

Relative strength +31%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $23 › 200d $18 — 50d above 200d

Institutional flow Accumulating

4 of 198 funds reported for Jun 30 · net +6 sh shares

Insider flow Distributing

Net -$140.0K over 90 days · 100% sells

Short interest Rising

9.93% of float · ▲ +14.3% MoM · 8.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

198 holders — near 2-yr high, broad support

Squeeze score 73

high risk · 0–100

Fundamentals

Strong

EPS growth +72%

Y/Y

Free cash flow $-370.2M

Balance sheet $89.7M

net cash

Quant / Vol

risk profile

Very High

Volatility 121%

annualized · 1-yr

Max drawdown −38%

past year

ATR 5.7%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Up next

Next earnings call

Aug 14, 2026 Est · unconfirmed · in 5 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 14, 2026

Technicals

trend & momentum for long-term holders Buy

1 · 2 · 4

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+64% Bullish

Price vs 50-day avg

+25% Bullish

RSI (14)

71 Bearish

MACD trend

Positive Bullish

52-week position

95% Bullish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $23 › 200d $18 — 50d above 200d

Institutional flow Accumulating

4 of 198 funds reported for Jun 30 · net +6 sh shares

Insider flow Distributing

Net -$140.0K over 90 days · 100% sells

Short interest Rising

9.93% of float · ▲ +14.3% MoM · 8.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

198 holders — near 2-yr high, broad support

Price context

position in its 52-week range

52-wk low $3 Now $29 · 95% 52-wk high $31

vs 200-day avg +64% vs 50-day avg +25%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
PASI 100 responses	39.5%	Week 24, Phase 3 ONWARD1 and ONWARD2	—
PASI 90 responses	62.1%	Week 24, Phase 3 ONWARD1 and ONWARD2	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
ALMS Alumis Inc. this stock	$3.73B	+199.9%	—	—	9.9%
ONC BeOne Medicines Ltd.	$446.53B	+1.7%	+22179.2%	908.7	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$132.55B	+15.2%	+46.2%	31.0	1.8%
REGN Regeneron Pharmaceuticals, Inc.	$70.90B	-12.3%	+20.8%	16.5	3.2%
ARGX Argenx SE	$57.49B	+9.4%	—	—	2.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

198

% held: 78.4%
Reported: 4 of 198
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

183

View

Short & Settlement

Short Interest Rising

Shares short

12.7M

Days to cover: 8.7d
Change: +1.6M sh

View

Short Volume

Short vol %

66%

As of: Jul 8, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $60
As of: Jun 11, 2026

View

Off-Exchange

Off-exchange %

47.9%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$140.0K

Buyers / Sellers: 0 / 1

Buyers Sellers

View

Financials

Revenue (FY)

$24.1M

Net income (FY): $-243.3M
EPS diluted: $-2.86

View

Filings

SEC Filings

Latest

8-K

Filed: Jul 2, 2026
This year: 11

View

Proposed Sales

Value

$140.0K

Shares: 5.0K
Filed: Jul 6, 2026

View

Exempt Offerings

Offering

$40.0M

Filed: Jul 24, 2024

View

Earnings & Events

Earnings Calls

Last call

May 14, 2026

View

Performance

	5D	20D	120D	MTD	YTD
ALMS	+7.9%	+53.6%	+38.8%	+4.0%	+199.9%
SPY	+0.9%	+1.4%	+7.6%	+0.1%	+9.7%
vs SPY	+6.9%	+52.2%	+31.2%	+3.9%	+190.3%

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance